Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)
Status: Forecasted
Posted date: December 11, 2024
Archive date: November 24, 2027
Close date: October 19, 2027
Opportunity ID: 357667
Opportunity number: PAR-25-296
Opportunity category: Discretionary
Agency name: National Institutes of Health
Agency code: HHS-NIH11
Award floor: $0
Award ceiling: $650,000
Cost sharing required: No
Funding Instrument Types
- Cooperative Agreement
Category of Funding Activity
- Health
- Income Security and Social Services
Eligible Applicants
- Public and State controlled institutions of higher education
Categories (use these for quoted searches)
- agency_code:hhs_nih11
- category_of_funding_activity:health
- category_of_funding_activity:income_security_and_social_services
- cost_sharing_or_matching_requirement:false
- eligible_applicants:public_and_state_controlled_institutions_of_higher_education
- funding_instrument_type:cooperative_agreement
- opportunity_category:discretionary
- status:forecasted
The CTSA Collaborative and Innovative Acceleration Award (CCIA) aims to accelerate the pace of translational research by supporting the collaborative development, dissemination, and sustainable implementation of innovative solutions across the CTSA Program Consortium and beyond. This Notice of Funding Opportunity (NOFO) invites investigator-initiated applications to develop, demonstrate, and disseminate innovative new approaches, technologies, resources, or models that increase the impact of research across diseases, transform the field of translational science, and bring more treatments for all people more quickly.